Nephros Inc expected to post a loss of 1 cent a share - Earnings Preview
03/03/2025 21:26
Nephros Inc NEPH.OQ NEPH.O is expected to show a rise in quarterly revenue when it reports results on March 5 (estimated) for the period ending December 31 2024 The South Orange New Jersey-based company is expected to report a 9.7% increase in revenue to $3.57 million from $3.25 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data. LSEG's mean analyst estimate for Nephros Inc is for a loss of 1 cent per share. The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Nephros Inc is $5.00, above its last closing price of $1.51. This summary was machine generated March 3 at 21:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)